PT-141 works by activating melanocortin receptors in the brain – the neurological pathways involved in the experience of sexual desire. This is a fundamentally different mechanism from medications that address physical response through blood flow or hormones.
For adults whose reduced desire has a neurological component, or who are not candidates for vascular approaches, PT-141 offers a clinician-evaluated alternative. Both men and women may be evaluated.